Company news

Cynata Therapeutics Limited news in 2017

Cynata Therapeutics Limited's news releases, calls and decks from 2017, newest first.

View company

Final Preclinical Asthma Study Confirms Efficacy

December 11, 2017

United States Patent Allowance for Core Cynata Technology

December 7, 2017

Enrolment Completed in 1st Cohort of Cynata Clinical Trial

November 14, 2017

September 2017 Quarterly Report

October 27, 2017

Notice of Annual General Meeting/Proxy Form

October 9, 2017

Cynata to Increase Exposure in Japan

October 8, 2017

US Patent Granted for Cynata Cymerus Technology

September 27, 2017

Health Canada Meeting Advances CYP Global Development Plans

August 31, 2017

Positive Data from CYP MSCs in 2nd Preclinical Asthma Study

August 23, 2017

June 2017 Quarterly Report

July 28, 2017

FDA Meeting Provides Clear Path for US Development Plans

July 4, 2017

Cynata Therapeutics GvHD Clinical Trial & Corporate Progress

June 27, 2017

CYP MSC Data in Asthma Model Published in Sceintific Journal

June 22, 2017

Cynata Files New Patent Application for Cymerus in Oncology

June 20, 2017

United States Patent for Core Cynata Technology

June 19, 2017

Treatment Commences in Cynatas World First Clinical Trial

May 16, 2017

March 2017 Quarterly Report

April 26, 2017

Cynata Advances to Pre-IND Meeting with US FDA

April 18, 2017

CYP Files for New Patent for Oncology Applications

April 12, 2017

CYP in Collaboration on Acute Respiratory Distress Syndrome

April 10, 2017

Cynata Partner apceth GmbH & Co Completes Cymerus Evaluation

March 30, 2017

CYP Advances Development of Cymerus for Treatment of Asthma

March 1, 2017

Final GvHD Preclinical Report Confirms Treatment Benefit

February 5, 2017

Positive Preliminary Data from Preclinical HeartAttack Study

February 1, 2017

Appendix 4C - quarterly

January 25, 2017

Cynata Successfully Completes Capital Raising

January 22, 2017

Cynata & FUJIFILM Sign Strategic Partnership Agreement

January 18, 2017

Decks in 2017